Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Garadacimab (fully human anti-FXIIa antibody) has been evaluated for long-term prophylaxis of HAE in a comprehensive clinical programme
Disclaimer: The contents of the Westlake Dermatology website, including text, graphics, and images, are for informational purposes only and are not intended to substitute for direct medical advice from your physician or other qualified professional.
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
We have also put together two infographics - 1) a roadmap for patients: Is the ongoing participation in proper diet and exercise being put back on the providers
84% were male
US$ 22.24
US$ 22.31
US$ 27.74
US$ 21.06
US$ 23.45
